Sama Achieves B Corp Recertification and Releases 2024 Impact Report
SAN FRANCISCO, CA / ACCESS Newswire / June 26, 2025 / Sama, the leader in purpose-built, responsible enterprise AI with agile data labeling for model training and performance evaluation, today announced its successful recertification as a Certified B Corporation™, marking a significant milestone in the company's commitment to balancing profit with purpose. The recertification comes alongside the release of Sama's 2024 Annual Impact Report, which details the company's progress across key environmental, social, and governance (ESG) initiatives.
Sama received an overall B Impact score of 118.4 from B Corp, up from 98.5 at initial certification in 2020. The new score affirms Sama's progress across governance, workforce development, community impact and environmental stewardship, exceeding the 80-point threshold required for B Corp status and more than doubling the median score of ordinary businesses. Full results of Sama's score can be found here.
B Corp companies are pioneers in establishing a fair, inclusive and regenerative economy, measured according to stringent criteria by B Lab across operations, including governance, community involvement, environmental impact and more.
"We are thrilled to recertify as B Corp, which offers independent proof that responsible AI can, and must, deliver measurable benefits to both people and planet," said Wendy Gonzalez, CEO of Sama. "Raising our score nearly 20 points reflects the thousands of decisions our teams made in recent years to embed ethics, transparency and sustainability deep into our business model."
Sama's recently published 2024 Impact Report details a year of accelerated stakeholder value that included:
17.1% reduction in absolute carbon emissions from the 2023 baseline, advancing the company's Science Based Targets initiative (SBTi) validated targets.23% of global electricity sourced from renewables, supported by partnerships with San Francisco's CleanSF program and Kenya's Malindi Solar Farm.New professional development and mentorship programs linking senior leaders with emerging talent in Kenya and Uganda, alongside the continuation of the Sama Scholarship Program for degree completion and launching key training programs to advance AI skills for digital workers.A successful Give Work Challenge, which included issuing new grants to high-potential social enterprises in East Africa through the Leila Janah Foundation.
Sama was recently recognized as one of the top three Inspiring Workplaces in 2025 across the Middle East and Africa, one of only two tech companies and the sole data-annotation provider on the list. The company was also recognized by Newsweek on its Greatest Workplaces for Women and Greatest Workplaces for Inclusion & Diversity lists.
About B Lab AfricaB Lab Africa is transforming the economy to benefit all people, communities, and the planet. A leader in economic systems change, our global network creates standards, policies, and tools for business, and we certify companies-known as B Corps-who are leading the way. To date, our global community includes over 9,500 B Corps in 104 countries and 160 industries, and over 6,100 companies in Africa manage their impact with the B Impact Assessment and the SDG Action Manager. https://b-labafrica.net/
About SamaSama is a global leader in data annotation solutions for computer vision, generative AI and large language models. Our solutions minimize the risk of model failure and lower the total cost of ownership through an enterprise ready ML-powered platform and SamaIQ™, actionable data insights uncovered by proprietary algorithms and a highly skilled on-staff team of over 5,000 data experts. 40% of FAANG companies and other major Fortune 50 enterprises, including GM, Ford and Microsoft, trust Sama to help deliver industry-leading ML models.
Driven by a mission to expand opportunities for underserved individuals through the digital economy, Sama is a certified B-Corp and has impacted more than 69,000 people since 2008. An MIT-led Randomized Controlled Trial has validated that Sama's training and employment programs generated meaningful employment- and income-related outcomes. For more information, visit www.sama.com.
Sama Media Contact:press@samasource.org
SOURCE: Sama
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
16 minutes ago
- Business Wire
Adagio Medical Reports Second Quarter 2025 Results
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ('Adagio' or 'the Company'), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced financial results for the second quarter ended June 30, 2025. Recent Business Highlights: Surpassed 85% enrollment in the FULCRUM-VT pivotal study of the Company's vCLAS™ Cryoablation System. The study, which seeks to enroll 206 patients with either ischemic or non-ischemic drug-refractory, recurrent, sustained monomorphic ventricular tachycardia ('VT') at 20 U.S. and Canadian centers, is on track for completion of patient enrollment in the second half of 2025 First-in-human results from the PARALELL study, which evaluated the safety and effectiveness of Adagio's Pulsed Field Cryoablation ('PFCA'), a novel, dual-energy cardiac ablation modality combining Pulsed Field Ablation (PFA) with Adagio's proprietary Ultra-Low Temperature Cryoablation ('ULTC'), were published in the Journal of Cardiovascular Electrophysiology Reduced cash burn quarter-over-quarter as a result of the Company's corporate prioritization initiative, which streamlined operations and focused resources on highest-value programs 'In the second quarter we saw continued strong momentum in the enrollment of our FULCRUM-VT study, which we believe validates the market need for our purpose-built technology and brings us one step closer to offering our proprietary ULTC solutions to patients in the United States who suffer from ventricular tachycardia,' said Todd Usen, Chief Executive Officer of Adagio. 'The team also made meaningful progress in advancing our pipeline through the continued development of our next-generation product, which is designed to improve usability for physicians while further enhancing the capabilities of our differentiated ULTC platform.' Second Quarter 2025 Financial Results Cost of revenue was $0.3 million for the three months ended June 30, 2025, compared to $0.7 million for the three months ended June 30, 2024. Research and development expenses were $2.0 million for the three months ended June 30, 2025 compared to $2.9 million for the three months ended June 30, 2024 Selling, general and administrative expenses were $2.4 million for the three months ended June 30, 2025, compared to $3.4 million for the three months ended June 30, 2024. Net loss for the three months ended June 30, 2025, was $3.9 million, or $(0.26) per share (Basic), compared to a net loss of $5.7 million, or $(7.35) per share (Basic), for the three months ended June 30, 2024. Reported cash and cash equivalents of $8.2 million as of June 30, 2025. About Adagio Medical Holdings, Inc. Adagio is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias utilizing its novel, proprietary, catheter-based Ultra-Low Temperature Cryoablation (ULTC) technology. ULTC is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The Company is currently focused on the treatment of ventricular tachycardia (VT) with its purpose-built vCLAS™ Cryoablation System, which is CE Marked and is currently under evaluation in the Company's FULCRUM-VT U.S. IDE Pivotal Study. About FULCRUM VT FULCRUM-VT (Feasibility of Ultra-Low Temperature Cryoablation in Recurring Monomorphic Ventricular Tachycardia) is a prospective, multi-center, open-label, single-arm study, enrolling 206 patients with structural heart disease of both ischemic and non-ischemic cardiomyopathy, indicated for catheter ablation of drug refractory VT in accordance with current treatment guidelines. The results of the study will be used to apply for FDA premarket approval (PMA) for Adagio's vCLAS™ Cryoablation System, potentially leading to the broadest industry indication for purely endocardial ablation of scar-mediated VT. Adagio's vCLAS™ Cryoablation System is commercially available for the treatment of monomorphic ventricular tachycardia in Europe and select other geographies but is limited to investigational use in the United States. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as 'anticipates,' 'believes,' 'expects,' 'intends,' 'projects,' 'plans,' and 'future' or similar expressions are intended to identify forward-looking statements. Forward-looking statements include statements concerning: the potential of Adagio's vCLAS™ Cryoablation System; Adagio's research, development and regulatory plans for its product candidates, including the timing of initiating additional trials and reporting data from its trials; the ability of Adagio to bring its proprietary ULTC solutions to patients in the United States who suffer from VT and their ability to improve usability for physicians; the potential for its product candidates to receive regulatory approval from the FDA or equivalent foreign regulatory agencies; and its current cash resources and the impacts of its corporate prioritization initiative and realignment of resources. Forward-looking statements are based on management's current expectations and are subject to various risks and uncertainties that could cause actual results to differ materially and adversely from those expressed or implied by such forward-looking statements. Accordingly, these forward-looking statements do not constitute guarantees of future performance, and you are cautioned not to place undue reliance on these forward-looking statements. Risks regarding Adagio's business are described in detail in Adagio's Securities and Exchange Commission ('SEC') filings, including in its Annual Report on Form 10-K for the full-year ended December 31, 2024, which is available on the SEC's website at Additional information will be made available in other filings that Adagio makes from time to time with the SEC. These forward-looking statements speak only as of the date hereof, and Adagio disclaims any obligation to update these statements except as may be required by law.
Business Wire
2 hours ago
- Business Wire
Wiland Expands MarketSignals™ Platform with Powerful New Brand and Category Signals Capabilities
NIWOT, Colo.--(BUSINESS WIRE)--Wiland, Inc., a leading provider of marketing data and predictive intelligence, today announced the addition of brand and category signals to its rapidly expanding MarketSignals™ platform. This new release brings powerful brand- and category-level insights to marketers seeking to optimize their strategies, conquer competitive challenges, and unlock growth across verticals such as retail, travel, dining, insurance, and more. 'With brand and category signals, we're giving marketers the clearest view yet into what drives consumer choice—insight that transforms targeting, retention, and growth strategies.' — Mike Gingell, CEO, Wiland Share Built from Wiland's immense consumer spending data—comprised of actual transactions from over 80 million individuals—brand and category signals deliver predictive signals for more than 220 top consumer brands and product categories. This expansion introduces granular, brand-specific elements such as purchase propensity, loyalty score, and lifetime value, giving marketers an unprecedented understanding of how their best customers—and their competitors'—behave across the marketplace. Wiland is adding new signals every two weeks and expects to increase coverage to over 500 brands and categories by the end of the year. 'With brand and category signals, we're empowering marketers with the clearest view yet of what drives consumer choice at the brand level,' said Mike Gingell, CEO of Wiland. 'This isn't just about knowing if someone is likely to shop at a specific retailer—it's about understanding the depth of that relationship, whether they're loyal, infrequent, or part of the moveable middle. These signals are transformative for marketers looking to personalize outreach, reduce churn, and drive smarter growth decisions.' Modeled from trillions of dollars in actual spend data, brand and category signals offer predictive insights in key behavioral dimensions—recency, frequency, and monetary value—across both brands and categories. These signals reveal: Who is buying from which brands How often they make purchases How loyal they are—or are not Whether they're currently in-market How much they are likely to spend over time Use cases range from uncovering brand conquesting opportunities and identifying competitive pressures, to segmenting audiences by customer value and loyalty. For example, a major brand can use brand and category signals to understand which of its loyal customers are shopping at competitors—or discover partnership opportunities through adjacencies. Unlike panels or opt-in loyalty data that reflect small slivers of consumer behavior, brand and category signals deliver insights across a vast, modeled universe of actual buyers. It enables brands to eliminate reliance on incomplete or unmatchable raw data and instead integrate high-performing predictive models directly into their analytics and AI systems. MarketSignals, which now includes FanSignals™, GivingSignals™, and TravelSignals™, continues to offer the most comprehensive and actionable view of consumer behavior across the U.S. economy. Every signal is built through Wiland's proprietary, fully automated modeling platform that assembles and refines data inputs with unmatched speed, precision, and scale. To learn more about Brand and category signals or the MarketSignals platform, visit ABOUT WILAND, INC. Wiland, Inc. is the marketing data and audiences company that leading brands and nonprofit organizations trust to help them develop and maintain robust customer and donor relationships that produce higher revenue, less advertising waste, and more profit. Wiland's data and audience products are informed by the largest set of detailed, individual-level spending signals ever assembled. The company's AI-enabled response prediction platform analyzes this vast information to deliver powerful insights and solutions that drive success across all addressable marketing channels. For more information about Wiland, visit
Business Wire
5 hours ago
- Business Wire
Paired Power Secures Patent for PairTree™ Solar-Integrated EV Charger System
CAMPBELL, Calif.--(BUSINESS WIRE)-- Paired Power, a leading manufacturer of solar-powered electric vehicle (EV) charging systems, announced the award of U.S. Patent No. 12,375,024 for its innovative PairTree™ solar canopy solution. The patent, titled 'Solar canopy systems and methods,' formally recognizes Paired Power's proprietary approach to solar canopy installation, significantly expanding the deployment speed and accessibility of electric vehicle charging in situations with limited or no grid power. This marks the company's fourth patent since 2016, reinforcing its position as the innovator in solar powered EV charging. The newly patented technology covers a unique method for raising solar panels above a foundation using an integrated lift mechanism. Unlike conventional canopy installations that require elevated work, scaffolding, or external lifts, the PairTree™ system allows panels to be safely assembled at ground level before being elevated into place. This streamlined approach reduces installation time, labor costs, and safety risks, making deployment of EV charging infrastructure faster with fewer approval bottlenecks in a wider range of environments. "Securing this patent for PairTree is a monumental achievement for Paired Power," said Tom McCalmont, CEO of Paired Power. 'It embodies our commitment to making sustainable energy solutions more accessible, efficient, and deployable for everyone, everywhere. The ability to rapidly install solar canopies with minimal effort will accelerate the adoption of electric vehicles by providing charging options in previously underserved locations." PairTree reduces installation time from weeks to hours, enabling rapid deployment with immediate functionality and minimal site disruptions. Unlike traditional EV chargers that require trenching and major construction, PairTree preserves existing parking spaces and reduces or eliminates reliance on the grid during installation. Paired Power's signature combination of solar power and energy storage allows PairTree to create its own self-powered microgrid, further enhancing the solution's utility for remote, off-grid or utility-constrained locations. By generating and storing its own energy, the system also empowers operators to avoid costly demand charges often levied by utilities during peak energy use. Its modular, flexible design enables fast, cost-effective EV charger deployment where and when it's needed most. To learn more about the PairTree™ system, visit To delve further into the company's full suite of microgrid EV charging solutions, join Paired Power on Thursday, September 18, for a live webinar at 2:00pm EDT/11:00am PDT. About Paired Power: Trusted by cities, governments, and leading corporations, Paired Power manufactures solar-powered microgrid electric vehicle charger facilities (EVCF) that enable rapid deployment of new EV infrastructure without requiring expansions of existing grid capacity. Paired Power's flagship products are PairTree™, a microgrid solar powered EV charger that pairs a 4.6kW solar array with a 42.4 kWh Battery Energy Storage System (BESS) to provide Level 2 EV charging day or night, and PairFleet™, a larger microgrid designed to serve greater numbers of vehicle charging needs and can be customized based on a client's energy requirements. For more information about Paired Power, visit
